ACURABLE
Acurable is a MedTech start-up headquartered in London. Acurable commercializes a wearable medical device able to accurately diagnose and manage respiratory conditions in a non-invasive way. Its award-winning patented technology is a major engineering innovation and the product of 10 years of research at Imperial College London. Acurable's medical devices has more accurate readings than current solutions, enabling automated diagnosis and drastically reducing misdiagnosis. It is non-invasive and requires no training, enabling home use without the assistance of a specialist or a visit to the hospital, which significantly lowers overall costs. Acurable aims to understand human biosignals so well that nobody dies of a treatable condition ever again.
ACURABLE
Industry:
Health Care Health Diagnostics Medical Device Software Wearables
Founded:
2016-08-03
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.acurable.com
Total Employee:
11+
Status:
Active
Total Funding:
13.67 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving Euro Apple Mobile Web Clips Icon Google Font API Google Analytics Content Delivery Network Global Site Tag Mobile Non Scaleable Content
Similar Organizations
aetherAI
aetherAI is a medical image AI company that focuses on improving digital pathology.
Artrya
Artrya uses artificial intelligence to deliver faster and more accurate diagnoses of Coronary Artery Disease.
contextflow
contextflow uses AI imaging technology to support radiologists during their daily clinical routine.
InnaMed
Launching HomeLab, a gateway to personalized healthcare in the comfort and privacy of your home. Measure + Analyze + Enhance.
Instadiagnostics
Instadiagnostics Inc., is developing a rapid, quantitative, point-of-care (POC) diagnostic platform.
Onera Health
Onera Health is a world-leading research center for nano electronics and digital technology company.
Quantitative Radiology Solutions
Quantitative Radiology Solutions offers advanced body-wide quantification of medical images.
Strados Labs
Strados Labs innovates respiratory monitoring using smart biosensors and artificial intelligence.
Current Advisors List
Board_member
2017-01-01
Current Employees Featured
Emilio Sanz Pereiras CEO @ Acurable
CEO
2016-01-01
Esther Rodriguez Villegas Founder, CEO and CSO @ Acurable
Founder, CEO and CSO
2016-01-01
Founder
Investors List
Kibo Ventures
Kibo Ventures investment in Series A - Acurable
Alma Mundi Ventures
Alma Mundi Ventures investment in Series A - Acurable
Comprador Holdings
Comprador Holdings investment in Series A - Acurable
KHP Ventures
KHP Ventures investment in Series A - Acurable
Kindred Capital
Kindred Capital investment in Series A - Acurable
Innovate UK
Innovate UK investment in Grant - Acurable
Kindred Capital
Kindred Capital investment in Seed Round - Acurable
Alma Mundi Ventures
Alma Mundi Ventures investment in Seed Round - Acurable
Official Site Inspections
http://www.acurable.com Semrush global rank: 600.61 K Semrush visits lastest month: 53.55 K
- Host name: 151.101.65.195
- IP address: 151.101.65.195
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "Acurable"
Acurable - Crunchbase Company Profile & Funding
Acurable is a MedTech start-up headquartered in London. Acurable commercializes a wearable medical device able to accurately diagnose and …See details»
About us - Acurable
Acurable is a venture-backed, fast growing, medical devices company, with offices in London and Seville. We create accurate, but very user-friendly, wearable medical devices intended to be used by patients themselves at …See details»
Acurable | Wearable Medical Devices
Patented technology resulting from over 10 years’ research at Imperial College London led by Acurable’s founder Prof. Esther Rodriguez-Villegas. Winner of an XPrize award, one of the most prestigious technology competitions in the …See details»
Acurable - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Oct 3, 2022: Series A - …See details»
Acurable 2025 Company Profile: Valuation, Funding
Acurable General Information Description. Developer of a wearable device designed to automatically and accurately measure breathing and cardiac vital …See details»
Meet the tiny, wireless sleep apnea diagnostic …
May 24, 2023 U.K. medtech startup Acurable has gained FDA clearance for a novel wireless diagnostic device for remote detection of obstructive sleep apnea (OSA). A formal launch into the U.S. market is slated ...See details»
Breakthrough medical device company Acurable among UK’s most …
London, 17 January 2025 – Medical device company Acurable has today been named as ‘one to watch’ in the inaugural edition of The Sunday Times 100 Tech, showcasing Britain’s fastest …See details»
Acurable Company Profile - Office Locations, Competitors ... - Craft
Acurable is a company that specializes in wearable medical devices. It offers products for the diagnosis of sleep apnoea in a non-invasive way as well as for continuous monitoring of …See details»
Acurable - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Mar 10, 2025 Acurable uses 12 technology products and services including HTML5, Bootstrap, and jQuery, according to G2 Stack. Acurable is actively using 33 technologies for its website, …See details»
A Chat with Esther Rodriguez-Villegas, Co-Founder at ... - TechRound
Nov 25, 2022 The first application of this technology brought to market by Acurable is AcuPebble SA100; a tiny, wearable sensor which is used to diagnose obstructive sleep apnoea (OSA). …See details»
Wearable Medical Devices Company Acurable Raises Funding
Oct 3, 2022 Acurable creates accurate and user-friendly wearable medical devices intended to be used by patients themselves at home. Its award-winning, patented AcuPebble technology …See details»
FDA OKs New Home Sleep Apnea Testing Device
Nov 30, 2021 Having obtained FDA clearance, Acurable’s focus over the next two years will be expansion into the North American market, where obstructive sleep apnea affects at least 25 …See details»
Sleep apnoea home testing device recommended for use in the NHS
Jan 16, 2025 Acurable’s alternative is a fully automated remote test for sleep apnoea that is small enough to be posted to patients and simple enough that they can carry the tests out …See details»
NICE recommends Acurable’s at-home sleep apnoea diagnostic
Dec 19, 2024 The UK’s National Institute for Health and Care Excellence (NICE) has recommended Acurable’s wearable AcuPebble device to support the remote diagnosis of …See details»
New Home Sleep Apnea Testing Device to Launch in US
Jun 6, 2023 United Kingdom-based medical device company Acurable will launch its AcuPebble device for obstructive sleep apnea diagnosis in the United States this summer after recently …See details»
Acurable prepares to challenge ResMed for sleep apnea diagnosis …
May 25, 2023 Dive Brief: Acurable is preparing to challenge ResMed and Resonea for the sleep apnea diagnosis market in the U.S. Having received 510(k) clearance in February, Acurable …See details»
Acurable
Acurable diagnosis system. Cookies Settings. This website uses cookies, for more information on how we use cookies refer to our Cookie Policy. In order to use this website you must accept …See details»
AcuPebble ® SA100 - Acurable
Validated diagnosis equivalent to ambulatory gold-standard (multi-channel polygraphy followed by manual specialist interpretation). Validated AHI and ODI based diagnoses for both 3% and 4% …See details»
AcuPebble â„¢ SA100 - Acurable
Validated sleep study result equivalent to ambulatory gold-standard (multi-channel polygraphy followed by manual specialist interpretation). Validated result based on AHI and ODI for both …See details»
AcuPebble ® RE100 - Acurable
AcuPebble RE100 is a wearable device that fundamentally improves the measurement of respiratory biosignals. It provides more accurate data and enables the continuous monitoring …See details»